Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

76.71 +0.05 (+0.07%)
Streaming Delayed Price Updated: 2:19 PM EST, Dec 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
News headline image
Cathie Wood Strengthens AI Chip Holdings With Nvidia And AMD Purchases, Reduces Palantir Position By Another $38.8 Million ↗
On Wednesday, May 7, 2025, Cathie Wood's Ark Invest Pours $24M Into Nvidia and AMD While Offloading $38.8M in Palantir Shares. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals ↗
Tempus AI shares rose after a Q1 beat, as an analyst highlighted its AI-driven growth, expanding pharma deals, and $1B+ contract value. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Warren Buffett Falls Behind Nancy Pelosi In Stock Market Returns Over The Last 11 Years: Here's What Data Shows ↗
Nancy Pelosi's investments over 11 years have outperformed the 'Oracle of Omaha', Warren Buffett's Berkshire Hathaway. 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Cathie Wood-Backed Tempus AI Says Pharma Contracts Solid Despite Biotech Funding Challenges, Tariff Pressures ↗
Tempus AI reassured investors that its major pharma contracts remain strong despite funding and tariff pressures. 
Via Benzinga
Topics Artificial Intelligence World Trade
News headline image
Tempus AI Strikes $200M Deal With AstraZeneca, Pathos To Build World's Largest Oncology Model ↗
The biggest strategic highlight for Tempus AI Inc. (NASDAQ: TEM) during the first quarter was a multi-million dollar deal to build "the world's largest foundation model for oncology." 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus AI Q1 Earnings: Revenue Beat, EPS Beat, Raised FY Guidance, Shares Surge ↗
Tempus AI reports first-quarter revenue of $255.74 million, beating estimates of $248.13 million. The AI-focused precision medicine and patient care company reports a first-quarter adjusted loss of 24... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Reports First Quarter 2025 Results
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI (TEM) Stock Lower Ahead Of Q1 Earnings Report, Notetaker AI Debut ↗
Tempus AI shares are trading lower by 1.3% Tuesday afternoon. The company will report its Q1 earnings after Tuesday's market close. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry
From Tempus AI, Inc.
Via Business Wire
News headline image
Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time. ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Jim Cramer: Sunrun Had 'Bad Couple Of Quarters,' ExlService Holdings Is 'Solid' ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying BlackRock, Inc. because "it's going to be a great position." 
Via Benzinga
News headline image
Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment
From Tempus AI, Inc.
Via Business Wire
News headline image
Is This the Best Nancy Pelosi Stock to Buy After a 40% Pullback? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection
From Tempus AI, Inc.
Via Business Wire
News headline image
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform
From Tempus AI, Inc.
Via Business Wire
News headline image
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
From FN Media Group LLC
Via GlobeNewswire
News headline image
Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio? ↗
Top mid-cap stock performers last week: Ascentage Pharma, Ardagh Metal, Bitdeer Tech, Pegasystems, Impinj, Lufax, Tempus AI, Kymera Therapeutics. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus to Report First Quarter 2025 Financial Results on May 6
From Tempus AI, Inc.
Via Business Wire
News headline image
Beyond The Numbers: 9 Analysts Discuss Tempus AI Stock ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now? ↗
Via The Motley Fool
Topics Artificial Intelligence Government Stocks
News headline image
Tempus AI Stock Is Ripping Higher Wednesday: What's Fueling The Move? ↗
Tempus AI Inc (NASDAQ:TEM) shares are surging Wednesday after the company announced a multi-year collaboration with AstraZeneca PLC (NASDAQ:AZN) and Pathos AI. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus AI Stock Surges Nearly 16% on Strategic Partnerships and AI-Driven Oncology Breakthroughs
April 23, 2025 – Tempus AI, Inc. (NASDAQ: TEM), a leading precision medicine company leveraging artificial intelligence (AI) for diagnostic and therapeutic advancements, saw its Class A Common Stock... 
Via MarketMinute
Topics Artificial Intelligence Stocks World Trade
News headline image
Why Tempus AI Stock Is Skyrocketing Today ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
From Tempus AI, Inc.
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.
From Tempus AI, Inc.
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.